Stent Companies in BioPortfolio's Corporate Database 
Stent company data on BioPortfolio. Our corporate data records list over 50,000 company records. Here you can see the latest Stent companies that have been added to our website.
Search For More Stent Companies
If you don't find the company you're looking for in the list below, you may wish to search our extensive database for further matches: Search for More Stent Companies.
More Information about Stent on BioPortfolio
We have published hundreds of Stent news stories on BioPortfolio along with dozens of Stent Clinical Trials. In addition to the corporate data, news and clinical trials, BioPortfolio also has a large collection of PubMed Articles about Stent for you to read.
Showing "stents stent" Companies 1 to 25 of 44
Lombard Medical Technologies PLC
Lombard Medical Technologies PLC is a global medical technology company focussed on providing innovative endovascular products which broaden clinicians’ treatment options and opportunities for treating more patients safely and more efficiently with Endovascular Aortic Repair (EVAR). Aorfix™ endovascular stent graft, Lombard Medical Technologies flagship product, addresses previousl...
Flexible Stenting Solutions Inc.
Flexible Stenting Solutions Inc. (FSS) is a leading developer of third-generation flexible peripheral arterial and biliary stents. Its fully connected stent has coupled technology with clinical needs by providing an atraumatic, highly durable and fatigue resistant stent with superior radial stiffness, flexibility and conformability. FSS staged launch of pr...
Cappella Medical Devices, Ltd.
Cappella, Inc. is a medical device company, developing novel solutions for the treatment of complex Coronary Artery Disease (CAD) and specifically bifurcation vascular disease. Cappellaâs initial product, the Sideguard® Coronary Sidebranch Stent & Delivery System offers interventional cardiologists a straightforward, effective solution that focuses...
Based in Princeton, N.J., and Paris, STENTYS has developed a new generation of stents to treat acute myocardial infarction (AMI). Founded by Jacques Séguin, M.D., Ph.D., (also founder of CoreValve, which was acquired by Medtronic) and Gonzague Issenmann, STENTYS received CE-marking for its flagship products in 2010. Its self-apposing stent adapts to the...
Cappella, Inc. is a medical device company that develops novel solutions for the treatment of complex coronary artery disease (CAD) focused on protecting the coronary sidebranch arteries. Cappellaâs Sideguard® coronary sidebranch technology offers interventional cardiologists a straightforward, effective, and easy to use solution that preserves the...
Based in Princeton, N.J., and Paris, Stentys has developed a new generation of stents for the treatment of acute myocardial infarction. Founded by Jacques Séguin, M.D., Ph.D., (founder of CoreValve, which was acquired last year by Medtronic for $700 million) and by Gonzague Issenmann, Stentys received CE Mark of its flagship products in 2010 and will st...
DSM Biomedical develops novel materials-based solutions to meet the present and future needs of the medical device and biopharmaceutical industries. Building on the expertise and strengths of DSM and its acquisition of The Polymer Technology Group, which is now known as DSM PTG, the companyâs product portfolio includes coatings, drug delivery platform...
Cappella, Inc. is a medical device company, developing novel solutions for the treatment of complex Coronary Artery Disease (CAD), specifically bifurcation disease. Cappellaâs initial product, the Sideguard® Coronary Sidebranch Stent & Delivery System offers interventional cardiologists a straightforward, effective solution that focuses on treating...
Micrus Endovascular Corporation
Micrus develops, manufactures and markets implantable and disposable medical devices for use in the treatment of cerebral vascular diseases. Micrus products are used by interventional neuroradiologists, interventional neurologists and endovascularly trained neurosurgeons to treat both cerebral aneurysms responsible for hemorrhagic stroke and intracranial a...
Headquartered in Italy and with manufacturing in Italy and Switzerland, Invatec is one of the worldâs fastest growing companies in the design, development and production of interventional cardiology and peripheral vascular products for the treatment of coronary and peripheral arterial disease. Driven by research and technology, Invatec actively collab...
Cappella Medical Devices Limited
Cappella, Inc. develops novel solutions for the treatment of complex coronary artery disease (CAD) - specifically bifurcation disease. Cappellaâs Sideguard® coronary sidebranch technology offers interventional cardiologists a straightforward, effective, solution that focuses on treating the sidebranch of diseased coronary arteries first, rather tha...
Novoste Corporation, based in Atlanta, Georgia, develops advanced medical treatments for coronary and vascular diseases and is the worldwide leader in vascular brachytherapy - radiation therapy delivered inside a blood vessel to prevent its reclosure (restenosis) following balloon angioplasty and other catheter-based interventional procedures. The NovosteT Beta-CathT System is commercially availab...
Tayside Flow Technologies Limited
TFT was formed in October 1998 as a spinout company from Tayside University Hospitals NHS TrustTayside Flow Technologies Ltd (TFT) is focused on the research, development and early stage commercialisation of vascular devices based on a new understanding of blood flow dynamics - Spiral Laminar Flow (SLF™ technology). The cardiovascular market is estimated at £11bn ($18bn equivalent) worldwide wi...
Samson Showalter Lepore Vascular Specialists
Our practice is the only medical practice in the Tri-county area dedicated to the treatment of patients with disorders of the veins and arteries, the Vascular System. Unlike most vascular surgical groups, we are also uniquely trained and experienced to offer all forms of diagnosis and therapy including:medications exercise therapy endovascular diagnosis and treatments (Angiography, Balloon angiopl...
XTENT, Inc. develops customizable drug-eluting stent (DES) systems for the treatment of coronary artery disease. XTENT's customizable DES systems are designed to enable the treatment of single lesions, long lesions and multiple lesions of varying lengths and diameters, in one or more arteries with a single device. Founded in 2001, XTENT was incubated by The Foundry (Redwood City, CA) and incorpora...
AbbeyMoor Medical Incorporated
AbbeyMoor Medical, Inc. develops and manufactures devices for the management of urinary voiding dysfunction. AbbeyMoor’s first product The Spanner™ Temporary Prostatic Stent is designed to provide relief for men following a minimally invasive treatment for BPH.
Envaste supplies medical device products, technologies and specialises in the manufacture of minimally invasive devices such as balloon catheters and stent delivery systems for the oem markets.
InspireMD is an innovative medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The company intends to apply its technology to develop products used in interventional cardiology and other vascular procedures. InspireMD's mission is to utilize its proprietary technology to make its products the industry standard for ste...
Opto Circuits (India) Ltd. (OCI) (BSE Code: 532391; NSE Symbol: OPTOCIRCUI) is an Indian MNC in the business of design, development, manufacture and marketing of healthcare equipment and interventional products. The product profile includes pulse oximeters, patient monitoring systems, sensors, digital thermometers anesthesia and respiratory care equipment, stents, catheters and other innovative pr...
Flexible Stenting Solutions, Inc.
Flexible Stenting Solutions Inc. (FSS) is a leading developer of third-generation flexible peripheral arterial, venous, neurovascular and biliary stents. Its fully connected stent has coupled technology with clinical needs by providing an atraumatic, highly durable and fatigue resistant stent with superior radial stiffness, flexibility and conformability....
Vascular Magnetics is developing novel therapeutic products based on the magnetic targeting of drug-loaded biodegradable particles. The companyâs first product in development is a treatment for peripheral artery disease that is designed to target anti-restenotic drugs specifically to diseased arterial sites and deliver doses not achievable with a drug...
Veryan was formed in 2003 as the result of a technology spin out from Imperial College, London, UK. Veryan’s BioMimics 3D technology is based on pioneering research by Professor Colin Caro into the link between blood flow mechanics and vascular disease. Veryan’s primary business focus is the development and commercialisation of novel vascular stent technology arising from this resear...
Based in Medford, Mass., AngioLight is an interventional cardiology medical device company founded to address unmet clinical needs in coronary and peripheral stenting. The company has developed a novel light-based diagnostic catheter to improve proper stent sizing and placement, and ultimately, patient outcomes.
Tryton Medical, Inc., located in Durham, N.C., is a leading developer of novel stent systems for the treatment of bifurcation lesions. The company's Side Branch Stent System, approved for sale in Europe, is designed to offer a dedicated strategy for treating these challenging cases. The privately held company is backed by Spray Ventures, PTV Sciences, and...
Arterial Remodeling Technologies (“ART”)
Arterial Remodeling Technologies (âARTâ) is developing bioresorbable coronary polymer stents that promote the natural remodeling of an injured artery after angioplasty. The Companyâs technology is based on intellectual property originating from three esteemed institutions: the Cleveland Clinic; the French national research institute, CNRS (Centre...
